Cargando…
1,4-Dihydropyridines: The Multiple Personalities of a Blockbuster Drug Family
More than 40 years after their introduction in therapy, 1,4-dihydropyridines (DHPs) are still amongst the most prescribed drugs in the world. Though they all share a similar mechanism of action blocking L-type voltage-gated Ca(2+) channels, DHPs differ in crucial pharmacological properties like tiss...
Autores principales: | Cataldi, Mauro, Bruno, Fiorentina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728803/ https://www.ncbi.nlm.nih.gov/pubmed/23905059 |
Ejemplares similares
-
SGLT2 Inhibitors: The Next Blockbuster Multifaceted Drug?
por: Chan, Jonathan C. H., et al.
Publicado: (2023) -
Pharmaceutical Drug Discovery: Designing the Blockbuster Drug
por: Cummins, David Jesse
Publicado: (2006) -
1,4-Dihydropyridine Antihypertensive Drugs: Recent Advances in Photostabilization Strategies
por: De Luca, Michele, et al.
Publicado: (2019) -
Artificial Intelligence: The Next Blockbuster Drug in Critical Care?
por: Azamfirei, Razvan
Publicado: (2023) -
Comparison between 1,2-Dihydropyridine and 1,4-Dihydropyridine on Hydride-Donating Ability and Activity
por: Zhang, Jin-Ye, et al.
Publicado: (2022)